
| Pair Name | Dihydroartemisinin, Sorafenib | ||
| Phytochemical Name | Dihydroartemisinin (PubChem CID: 3000518 ) | ||
| Anticancer drug Name | Sorafenib (PubChem CID: 216239 ) | ||
| Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
| Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
||
| Pair Name | Dihydroartemisinin, Sorafenib | |||
| Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
| Biological Phenomena | Induction-->Ferroptosis | |||
| Gene Regulation | Up-regulation | Expression | ROS1 | hsa6098 |
| Up-regulation | Expression | SMG1 | hsa23049 | |
| Down-regulation | Expression | GSS | hsa2937 | |
| Down-regulation | Expression | SLC7A11 | hsa23657 | |
| Down-regulation | Expression | GCLC | hsa2729 | |
| Down-regulation | Expression | GPX4 | hsa2879 | |
| Down-regulation | Expression | HMOX1 | hsa3162 | |
| In Vitro Model | Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 |
| SW480 | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0546 | |
| In Vivo Model | 5×10⁶ of HepG2 cells were injected into the right flank of 6-week-old athymic female mice (Balb/c nude mice). | |||
| Result | DHA and Sora had the same mechanism, and the combined application of them could have a synergistic anti-tumor effect by inducing ferroptosis and inhibiting energy metabolism in HepG2 cells. | |||
| No. | Title | Href |
|---|---|---|
| 1 | Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism. J Pharmacol Sci. 2022 Jan;148(1):73-85. doi: 10.1016/j.jphs.2021.09.008. | Click |